Research Topics
| James I HudsonSummaryAffiliation: Harvard University Country: USA Publications
| Collaborators
|
Detail Information
Publications
A structural approach to the familial coaggregation of disordersJames I Hudson
Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
Epidemiology 19:431-9. 2008..For illustration, we applied our method to a family study of binge eating disorder and bipolar disorder...
Features of men with anabolic-androgenic steroid dependence: A comparison with nondependent AAS users and with AAS nonusersGen Kanayama
Biological Psychiatry Laboratory, McLean Hospital Harvard Medical School, 115 Mill Street, Belmont, MA 02478, United States
Drug Alcohol Depend 102:130-7. 2009..Anabolic-androgenic steroid (AAS) dependence has been a recognized syndrome for some 20 years, but remains poorly understood...
Family study of affective spectrum disorderJames I Hudson
Department of Psychiatry, Harvard Medical School, Boston, Mass, USA
Arch Gen Psychiatry 60:170-7. 2003..Two predictions of the ASD hypothesis were tested: that ASD, taken as a single entity, would aggregate in families and that MDD would coaggregate with other forms of ASD in families...- Duloxetine in the treatment of major depressive disorder: an open-label studyJames I Hudson
McLean Hospital, Belmont, MA, USA
BMC Psychiatry 7:43. 2007..In this study, the safety and efficacy of duloxetine, a potent dual reuptake inhibitor of 5-HT and NE, were examined... - Longitudinal study of the diagnosis of components of the metabolic syndrome in individuals with binge-eating disorderJames I Hudson
McLean Hospital, Belmont, MA 02478, USA
Am J Clin Nutr 91:1568-73. 2010..Binge-eating disorder may represent a risk factor for the metabolic syndrome... - Family study of fibromyalgia and affective spectrum disorderJames I Hudson
Biological Psychiatry Laboratory, McLean Hospital Department of Psychiatry, Harvard Medical School, Belmont, MA 02478, USA
Biol Psychiatry 56:884-91. 2004..Two predictions of the ASD hypothesis were tested: ASD, taken as a single entity, aggregates in families; and fibromyalgia coaggregates with other forms of ASD in families... - The cross-sectional cohort study: an underutilized designJames I Hudson
Biological Psychiatry Laboratory, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
Epidemiology 16:355-9. 2005..Such situations often arise when studying chronic or episodic conditions with low mortality, such as psychiatric disorders... - Binge-eating disorder as a distinct familial phenotype in obese individualsJames I Hudson
Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, Mass 02478, USA
Arch Gen Psychiatry 63:313-9. 2006..However, it remains unclear whether BED represents an etiologically distinct behavioral phenotype of obesity or simply a nonspecific eating pattern sometimes seen in obese individuals... - The prevalence and correlates of eating disorders in the National Comorbidity Survey ReplicationJames I Hudson
Department of Psychiatry, Harvard Medical School and Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
Biol Psychiatry 61:348-58. 2007..Little population-based data exist on the prevalence or correlates of eating disorders... - By how much will the proposed new DSM-5 criteria increase the prevalence of binge eating disorder?James I Hudson
Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA
Int J Eat Disord 45:139-41. 2012..To estimate how much the prevalence of binge eating disorder will increase under the new proposed DSM-5 criteria, which relax the requirements for the frequency and duration of eating binges... - Genetic epidemiology of eating disorders and co-occurring conditions: the role of endophenotypesJames I Hudson
Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
Int J Eat Disord 40:S76-8. 2007 - Topiramate in the long-term treatment of binge-eating disorder associated with obesitySusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
J Clin Psychiatry 65:1463-9. 2004..This study assessed the long-term effectiveness and tolerability of topiramate in binge-eating disorder (BED) with obesity... - Comorbidity of fibromyalgia and psychiatric disordersLesley M Arnold
Women s Health Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45219, USA
J Clin Psychiatry 67:1219-25. 2006..To assess the co-occurrence of fibromyalgia with psychiatric disorders in participants of a fibromyalgia family study... - Binge eating disorder: a stable syndromeHarrison G Pope
Department of Psychiatry, Harvard Medical School and McLean Hospital, Belmont, MA 02478, USA
Am J Psychiatry 163:2181-3. 2006..This study assessed the stability of binge eating disorder in a community sample... - Co-occurrence of binge eating disorder with psychiatric and medical disordersKristin N Javaras
Department of Biostatistics, Harvard School of Public Health, Boston, Mass, USA
J Clin Psychiatry 69:266-73. 2008..We used data from that type of study to assess the co-occurrence of various psychiatric and medical disorders with DSM-IV BED and with subthreshold BED... - Residual neurocognitive features of long-term ecstasy users with minimal exposure to other drugsJohn H Halpern
Laboratory for Integrative Psychiatry Biological Psychiatry Laboratory Cognitive and Clinical Neuroimaging Core Brain Imaging Center McLean Hospital, Belmont, MA, USA
Addiction 106:777-86. 2011..We designed an investigation seeking to minimize these possible sources of bias... - Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trialAnna I Guerdjikova
Department of Psychiatry, University of Cincinnati College of Medicine, Lindner Center of HOPE, Mason, Ohio 45040, USA
Int Clin Psychopharmacol 24:150-8. 2009..As a result of an exceptionally high placebo response, it is likely that for efficacy measures except for body weight and metabolic indices, the study was incapable of detecting potentially clinically important drug-placebo difference... - Efficacy of sibutramine for the treatment of binge eating disorder: a randomized multicenter placebo-controlled double-blind studyDenise E Wilfley
Department of Psychiatry, Washington University School of Medicine, St Louis, MO 63110, USA
Am J Psychiatry 165:51-8. 2008..This study is the first large-scale, multisite, placebo-controlled trial to test the efficacy of sibutramine in binge eating disorder... - Citalopram in the treatment of binge-eating disorder: a placebo-controlled trialSusan L McElroy
Division of Psychopharmacology Research and Eating Disorders, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
J Clin Psychiatry 64:807-13. 2003..Citalopram is a highly selective serotonin reuptake inhibitor antidepressant. The purpose of this study was to assess the efficacy and safety of citalopram in the treatment of binge-eating disorder... - Zonisamide in the treatment of binge eating disorder with obesity: a randomized controlled trialSusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
J Clin Psychiatry 67:1897-906. 2006..Binge eating disorder (BED) is associated with obesity. Zonisamide is a novel antiepileptic drug associated with weight loss. The purpose of this study was to evaluate zonisa-mide in the treatment of BED associated with obesity... - Family history study of the familial coaggregation of borderline personality disorder with axis I and nonborderline dramatic cluster axis II disordersMary C Zanarini
Laboratory for the Study for Adult Development and the Psychiatric Epidemiology Research Program, McLean Hospital, and the Department of Psychiatry, Harvard Medical School, USA
J Pers Disord 23:357-69. 2009..Taken together, the results of this study suggest that common familial factors, particularly in the areas of affective disturbance and impulsivity, contribute to borderline personality disorder... - Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort studyHarrison G Pope
Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
Biol Psychiatry 71:254-61. 2012..Almost all AAS abusers are male and lift weights, but the risk factors for AAS use among male weightlifters remain poorly understood... - Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorderLesley M Arnold
Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH, USA
Clin J Pain 25:461-8. 2009..To investigate whether comorbid major depressive disorder (MDD) influenced the efficacy and safety of duloxetine in treating fibromyalgia (FM)... - What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetineJames I Hudson
Harvard Medical School McLean Hospital, Belmont, Massachusetts, USA
J Rheumatol 36:2517-22. 2009..To investigate the relationship between changes in clinical rating scale items and endpoint Patient Global Impression of Improvement (PGI-I)... - Duloxetine in the treatment of irritable bowel syndrome: an open-label pilot studyBrian P Brennan
Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
Hum Psychopharmacol 24:423-8. 2009..To assess the efficacy of duloxetine for irritable bowel syndrome (IBS)... - A placebo-controlled, randomized trial of fluoxetine in the treatment of binge-eating disorderLesley M Arnold
Women s Health Research Program, Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio, USA
J Clin Psychiatry 63:1028-33. 2002..The purpose of this study was to assess the efficacy and safety of fluoxetine in the treatment of binge-eating disorder... - Body image and attitudes toward male roles in anabolic-androgenic steroid usersGen Kanayama
McLean Hospital, 115 Mill St, Belmont, MA 02478, USA
Am J Psychiatry 163:697-703. 2006..In particular, the authors compared current versus past AAS users and short-term versus long-term users in this respect... - Atomoxetine in the treatment of binge-eating disorder: a randomized placebo-controlled trialSusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
J Clin Psychiatry 68:390-8. 2007..Binge-eating disorder (BED) is associated with obesity. Atomoxetine is a highly selective norepinephrine reuptake inhibitor associated with weight loss. The purpose of this study was to evaluate atomoxetine in the treatment of BED... - High-dose escitalopram in the treatment of binge-eating disorder with obesity: a placebo-controlled monotherapy trialAnna I Guerdjikova
Division of Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
Hum Psychopharmacol 23:1-11. 2008..The purpose of this study was to evaluate the efficacy and safety of high-dose escitalopram in the treatment of binge-eating disorder (BED) associated with obesity... - Topiramate in the treatment of binge eating disorder associated with obesity: a randomized, placebo-controlled trialSusan L McElroy
Division of Psychopharmacology Research, Department of Psychiatry, University of Cincinnati College of Medicine, OH 45267 0559, USA
Am J Psychiatry 160:255-61. 2003..Binge eating disorder is associated with obesity. Topiramate is an antiepileptic agent associated with weight loss. The objective of this study was to evaluate topiramate in the treatment of binge eating disorder associated with obesity... - Treatment of anabolic-androgenic steroid dependence: Emerging evidence and its implicationsGen Kanayama
Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA, USA
Drug Alcohol Depend 109:6-13. 2010..Indeed, the opioid antagonist naltrexone blocks AAS dependence in animals. By inference, pharmacological and psychosocial treatments for human opioid dependence might also benefit AAS-dependent individuals... - Topiramate for the treatment of binge eating disorder associated with obesity: a placebo-controlled studySusan L McElroy
Psychopharmacology Research Program, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
Biol Psychiatry 61:1039-48. 2007..The current investigation evaluated the safety and efficacy of topiramate in a multicenter, placebo-controlled trial... - Memantine in the treatment of binge eating disorder: an open-label, prospective trialBrian P Brennan
Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
Int J Eat Disord 41:520-6. 2008..To assess preliminarily the efficacy of memantine in binge eating disorder... - Parallel-group placebo-controlled trial of testosterone gel in men with major depressive disorder displaying an incomplete response to standard antidepressant treatmentHarrison G Pope
Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
J Clin Psychopharmacol 30:126-34. 2010..The possibility remains that testosterone might benefit a particular subgroup of depressed men, but if so, the characteristics of this subgroup would still need to be established... - Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trialLesley M Arnold
University of Cincinnati College of Medicine, Cincinnati, Ohio 45219, and Newton Wellesley Hospital, Newton, MA, USA
Arthritis Rheum 56:1336-44. 2007..To assess the efficacy and safety of gabapentin in patients with fibromyalgia... - Pharmacologic treatment of binge eating disorderWilliam P Carter
Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
Int J Eat Disord 34:S74-88. 2003..To review the findings from pharmacologic trials of binge eating disorder (BED) and to provide guidelines for pharmacologic treatment... - Zonisamide in the treatment of binge-eating disorder: an open-label, prospective trialSusan L McElroy
Division of Clinical Neuroscience, Department of Psychiatry, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
J Clin Psychiatry 65:50-6. 2004..It commonly co-occurs with obesity. Zonisamide is a novel antiepileptic drug associated with weight loss. The purpose of this study was to preliminarily assess zonisamide in the treatment of binge-eating disorder... - Familiality and heritability of binge eating disorder: results of a case-control family study and a twin studyKristin N Javaras
Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts, USA
Int J Eat Disord 41:174-9. 2008..To estimate the familiality and heritability of binge eating disorder (BED)... - Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunctionAaron L Baggish
Division of Cardiology, Massachusetts General Hospital, and Department of Medicine, Harvard Medical School, Boston, Mass 02114, USA
Circ Heart Fail 3:472-6. 2010..We compared cardiac parameters in weightlifters reporting long-term AAS use to those in otherwise similar weightlifters without prior AAS exposure... - The subsyndromal phenomenology of borderline personality disorder: a 10-year follow-up studyMary C Zanarini
Laboratory for the Study of Adult Development and the Psychiatric Epidemiology Research Program, McLean Hospital, 115 Mill St, Belmont 02478, and the Department of Psychiatry, Harvard Medical School, Boston, MA, USA
Am J Psychiatry 164:929-35. 2007..The purpose of this study was to characterize the course of 24 symptoms of borderline personality disorder in terms of time to remission... - Safety and tolerability of duloxetine in the treatment of major depressive disorder: analysis of pooled data from eight placebo-controlled clinical trialsJames I Hudson
McLean Hospital, Belmont, MA, USA
Hum Psychopharmacol 20:327-41. 2005..CONCLUSION: These results are consistent with those obtained previously from smaller pooled data sets, and suggest that duloxetine is safe and well tolerated in patients with MDD... - Anabolic-androgenic steroid dependence: an emerging disorderGen Kanayama
Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts, and Department of Psychiatry, Harvard Medical School, Boston, MA, USA
Addiction 104:1966-78. 2009..Here we review the accumulating human and animal evidence showing that AAS may cause a distinct dependence syndrome, often associated with adverse psychiatric and medical effects... - Family study of borderline personality disorder and its sectors of psychopathologyJohn G Gunderson
The Borderline Center, McLean Hospital, Belmont, MA 02478
Arch Gen Psychiatry 68:753-62. 2011..The familiality of borderline personality disorder (BPD) and its sectors of psychopathology are incompletely understood... - Long-term psychiatric and medical consequences of anabolic-androgenic steroid abuse: a looming public health concern?Gen Kanayama
Biological Psychiatry Laboratory, McLean Hospital Harvard Medical School, 115 Mill Street, Belmont, MA 02478, United States
Drug Alcohol Depend 98:1-12. 2008..The senior members of this population are now entering middle age; they represent the leading wave of a new type of aging former substance abusers, with specific medical and psychiatric risks... - Human growth hormone abuse in male weightliftersBrian P Brennan
Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
Am J Addict 20:9-13. 2011..These findings suggest that among young male weightlifters, illicit HGH use has become a common form of substance abuse, frequently associated with both AAS dependence and classical substance dependence. .. - Is PTSD caused by traumatic stress?J Alexander Bodkin
Clinical Psychopharmacology Research Program, McLean Hospital, Belmont, MA 02478, USA
J Anxiety Disord 21:176-82. 2007..This equivalence suggests that in a treatment-seeking population, caution should be exercised in attributing the PTSD syndrome to trauma... - A diagnostic interview module for anabolic-androgenic steroid dependence: preliminary evidence of reliability and validityHarrison G Pope
Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts 02478, USA
Exp Clin Psychopharmacol 18:203-13. 2010..Collectively, these findings suggest that AAS dependence may be diagnosed reliably, with preliminary evidence for construct and discriminant validity... - Risk factors for anabolic-androgenic steroid use among weightlifters: a case-control studyGen Kanayama
Biological Psychiatry Laboratory, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
Drug Alcohol Depend 71:77-86. 2003..These findings suggest that AAS use may be most likely to occur in men with high levels of antisocial traits and low levels of body esteem... - Illicit anabolic-androgenic steroid useGen Kanayama
Biological Psychiatry Laboratory, McLean Hospital, Belmont, and Harvard Medical School, Boston, MA 02478, USA
Horm Behav 58:111-21. 2010..Finally, AAS may cause a dependence syndrome in a substantial minority of users. AAS dependence may pose a growing public health problem in future years but remains little studied... - Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzoleBrian P Brennan
Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
Neuropsychopharmacology 35:834-46. 2010..Further investigation of the Gln/Glu ratio as a possible early biomarker of response to glutamate-modulating therapies is warranted... - Anabolic steroid users' attitudes towards physiciansHarrison G Pope
Biological Psychiatry Laboratory, McLean Hospital Harvard Medical School, Belmont, MA 02478, USA
Addiction 99:1189-94. 2004..To assess anabolic-androgenic steroid (AAS) users' trust in the knowledge and advice of physicians... - Anabolic steroid abuse among teenage girls: an illusory problem?Gen Kanayama
Biological Psychiatry Laboratory, McLean Hospital Harvard Medical School, 115 Mill Street, Belmont, MA 02478, USA
Drug Alcohol Depend 88:156-62. 2007..We questioned whether AAS use among teenage girls was as widespread as claimed... - Psychological and cognitive effects of long-term peyote use among Native AmericansJohn H Halpern
Biological Psychiatry Laboratory, Alcohol and Drug Abuse Research Center, Harvard Medical School, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
Biol Psychiatry 58:624-31. 2005..However, the long-term residual psychological and cognitive effects of hallucinogens remain poorly understood... - Borderline psychopathology in the first-degree relatives of borderline and axis II comparison probandsMary C Zanarini
The Laboratory for the Study for Adult Development, McLean Hospital, and the Department of Psychiatry, Harvard Medical School, Belmont, MA 02478, USA
J Pers Disord 18:439-47. 2004..Taken together, the results of this study suggest that the subsyndromal phenomenology of BPD may be more common than the borderline diagnosis itself... - Response to R. E. Goldsmith, R. E. Cheit, & m. E. Wood, "evidence of dissociative amnesia in science and literature: culture-bound approaches to trauma in pope et Al. (2007)"Harrison G Pope
Department of Psychiatry, Harvard Medical School and Biological Psychiatry Laboratory, McLean Hospital, Belmont, Massachusetts, USA
J Trauma Dissociation 10:254-7. 2009..We invite interested readers first to review the issues of misinterpretation discussed by McNally and then to carefully compare the methodological discussion in our original paper with that of Goldsmith and colleagues... - Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugsJohn H Halpern
Alcohol and Drug Abuse Research Center, Harvard Medical School, Biological Psychiatry Laboratory, McLean Hospital, 115 Mill Street, Belmont, MA 02478 9106, USA
Drug Alcohol Depend 75:135-47. 2004..Most MDMA users, however, use other illicit drugs as well, so it is difficult to be certain that these deficits are due to MDMA, as opposed to other drug use or additional confounding factors... - Cognitive deficits in long-term anabolic-androgenic steroid usersGen Kanayama
Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA
Drug Alcohol Depend 130:208-14. 2013..These findings raise the possibility, apparently still untested, that humans using high-dose AAS might eventually develop cognitive deficits... - A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgiaLesley M Arnold
Women's Health Research Program, Department of Psychiatry, University of Cincinnati Medical Center, Cincinnati, Ohio 45267-0559, USA
Am J Med 112:191-7. 2002..CONCLUSIONS: In a 12-week, flexible-dose, placebo-controlled trial, fluoxetine was found to be effective on most outcome measures and generally well tolerated in women with fibromyalgia... - Is dissociative amnesia a culture-bound syndrome? Findings from a survey of historical literatureHarrison G Pope
Biological Psychiatry Laboratory, McLean Hospital, Belmont, MA 02478, USA
Psychol Med 37:225-33. 2007..We asked whether 'dissociative amnesia' was similarly documented throughout history... - Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trialHarrison G Pope
Biological Psychiatry Laboratory, McLean Hospital, 115 Mill St, Belmont, MA 02478 9106, USA
Am J Psychiatry 160:105-11. 2003..In an 8-week randomized, placebo-controlled trial, the authors administered a testosterone transdermal gel to men aged 30-65 who had refractory depression and low or borderline testosterone levels... - Family studies of borderline personality disorder: a reviewCandace N White
McLean Hospital, Belmont, Mass. 02478, USA
Harv Rev Psychiatry 11:8-19. 2003..Because of significant methodological problems, most notably indirect assessments and inadequate sample size, major questions persist about the familial aggregation of this disorder that require more definitive methods... - Tracking scientific interest in the dissociative disorders: a study of scientific publication output 1984-2003Harrison G Pope
Biological Psychiatry Laboratory, McLean Hospital, and Department of Psychiatry, Harvard Medical School, Belmont, MA 02478, USA
Psychother Psychosom 75:19-24. 2006..We attempted to track scientific interest in dissociative amnesia and dissociative identity disorder by estimating the annual output of publications regarding these entities over the last 20 years... - Early-onset cannabis use and cognitive deficits: what is the nature of the association?Harrison G Pope
Department of Psychiatry, Harvard Medical School, McLean Hospital, 115 Mill Street, Belmont, MA 02478, USA
Drug Alcohol Depend 69:303-10. 2003..Individuals who initiate cannabis use at an early age, when the brain is still developing, might be more vulnerable to lasting neuropsychological deficits than individuals who begin use later in life... - Cognitive measures in long-term cannabis usersG Pope Harrison
Biological Psychiatry Laboratory, McLean Hospital/Harvard Medical School, Belmont, Massachusetts 02478, USA
J Clin Pharmacol 42:41S-47S. 2002.... - Body fat perception in eating-disordered menBarbara Mangweth
Department of Psychiatry, University Clinics Innsbruck, Anichstr 35, A 6020, Austria
Int J Eat Disord 35:102-8. 2004..We sought to assess the relative roles of body fat ideals and body fat perception in men with eating disorders... - Family study of fibromyalgiaLesley M Arnold
University of Cincinnati College of Medicine, Cincinnati, Ohio 45267 0559, USA
Arthritis Rheum 50:944-52. 2004..To assess for familial aggregation of fibromyalgia (FM) and measures of tenderness and pain, and for familial coaggregation of FM and major mood disorder (major depressive disorder or bipolar disorder)... - Comment on: Familial aggregation of depression in fibromyalgia: a community-based test of alternative hypotheses, Raphael et al., Pain 110 (2004) 449-460Lesley M Arnold
Pain 112:409-10; author reply 410. 2004 - Childhood body-focused behaviors and social behaviors as risk factors of eating disordersBarbara Mangweth
Department of Psychiatry, Innsbruck University Hospitals, Innsbruck, Austria
Psychother Psychosom 74:247-53. 2005.... - Outcomes of surgical management of total HIP replacement in patients aged 65 years and older: cemented versus cementless femoral components and lateral or anterolateral versus posterior anatomical approachSheryl Zimmerma
Cecil G Sheps Center for Health Services Research, The University of North Carolina at Chapel Hill, 27599 7590, USA
J Orthop Res 20:182-91. 2002....